Indaptus Therapeutics, Inc. (INDP) Financials

INDP Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 14.9 million 2.8 million
2023-09-30 17.8 million 2.5 million
2023-06-30 20.8 million 2.2 million
2023-03-31 23.1 million 2.0 million

INDP Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -2.6 million 745525
2023-09-30 -3.7 million 764803
2023-06-30 -2.1 million 728466
2023-03-31 -5.0 million 727144

INDP Net Income

No data available :(

INDP Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 13.4 million - 175053
2023-09-30 16.0 million - 196241
2023-06-30 19.7 million - 216591
2023-03-31 21.7 million - 236506

INDP Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 8.4 million
2023-09-30 8.4 million
2023-06-30 8.4 million
2023-03-31 8.4 million

INDP Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 2.0 million 2.1 million -
2023-09-30 - 2.2 million 2.0 million -
2023-06-30 - 1.5 million 2.0 million -
2023-03-31 - 1.9 million 2.6 million -

INDP Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 320
2023-09-30 - 321
2023-06-30 - 322
2023-03-31 - 321

INDP

Price: $2.03

52 week price:
1.56
4.08

Earnings Per Share: -1.83 USD

P/E Ratio: -0.91

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 19752

Market Capitalization: 23.7 million

Links: